CRISPR
Beyond COVID-19, Proof Dx Plans Infectious Disease, Oncology Tests for CRISPR-Based POC System
Premium
Proof Diagnostics recently submitted a CRISPR-based, point-of-care test for SARS-COV-2 to the US Food and Drug Administration for Emergency Use Authorization.
IDbyDNA Nabs Additional Funding for Gene Editing Dx, Biosurveillance Tech
In collaboration with other firms, IDbyDNA is using precision metagenomics to develop a next-generation device for diagnostic testing of emerging infectious diseases.
Sherlock Biosciences Raises $80M in Series B Financing
The company will use the funding to develop diagnostic tests based on CRISPR and synthetic biology that can operate without complex instrumentation.
Broad Institute, Collaborators Eye CRISPR Panel to Detect SARS-CoV-2 Variants, Respiratory Viruses
Premium
The group has developed a panel to detect SARS-CoV-2, other coronaviruses, and influenza A and B that also identified and differentiated six variant lineages.
Medix Biochemica Acquires German MDx Raw Materials Producer MyPols Biotec
Medix Biochemica said MyPols Biotec's products complement its portfolio of IVD raw materials and expand its molecular diagnostics reagent offerings.